A Drug Enforcement Administration inspection of a long-term care facility pharmacy reaches further than a typical retail audit. Investigators check whether each automated dispensing system installed at a nursing home or assisted living facility carries its own separate DEA registration, whether faxed Schedule II prescriptions for residents were retained as required, and whether partial-fill records show the dates, quantities, and balances the regulation demands. A long-term care (LTC) pharmacist-in-charge who assumes one retail registration covers every facility served is already behind before the inspector arrives.
Automated Dispensing System Registration at Each Facility
Under 21 CFR 1300.01, an automated dispensing system is a mechanical system that stores, packages, counts, labels, and dispenses medications and that collects and maintains all transaction information; it does not include compounding or administration. 21 CFR 1301.27 requires a retail pharmacy that installs and operates one of these systems at a long-term care facility to hold a separate DEA registration for that location, and a second pharmacy operating a system at the same facility needs its own separate registration too. No unregistered person may install or operate the system at all.
The application for that separate registration carries its own paperwork. 21 CFR 1301.17(c) requires a notarized affidavit confirming the state board of pharmacy or licensing agency has authorized the facility's automated dispensing system, naming the facility, the authorization date, and the person who signed it. A false statement in that affidavit exposes the signer and the pharmacy to registration denial or revocation under 21 U.S.C. 824(a), and to prosecution under 21 U.S.C. 843. Pharmacies that pick up a new long-term care contract, or that go through a change of ownership, should confirm that each facility-specific registration survived the transition; our guide to DEA Registration and Change of Pharmacy Ownership covers that process.
Faxed and Partially Filled Schedule II Prescriptions for Residents
21 CFR 1306.11(f) lets a practitioner or the practitioner's agent transmit a Schedule II prescription for a long-term care facility resident to the dispensing pharmacy by facsimile; the fax itself serves as the original prescription and must be maintained under 21 CFR 1304.04(h). 21 CFR 1306.13(c) then allows that Schedule II prescription to be filled in partial quantities, down to individual dosage units, for a patient in a long-term care facility or a patient with a documented terminal illness. The prescription is valid for up to 60 days from the issue date unless the medication is discontinued sooner, but only if the pharmacist records the notation "LTCF patient" or "terminally ill" on the prescription.
A partial fill that does not carry the "LTCF patient" or "terminally ill" notation on its face is deemed filled in violation of the Controlled Substances Act, regardless of how the medication was actually used.
Recordkeeping That DEA Reviews During an Inspection
21 CFR 1304.04(h) requires a registered pharmacy to maintain inventories and records of Schedule I and II substances separately from all other pharmacy records, and to keep paper Schedule II prescriptions in a separate prescription file at the registered location. Schedule III, IV, and V records may be kept separately or combined with ordinary business records if they stay readily retrievable. For each partially filled Schedule II prescription tied to a long-term care resident, 21 CFR 1306.13(d) permits a computerized system to replace the paper record only if it can output the original prescription number, the prescriber's and patient's identification, the long-term care facility's address, the medication authorized, a listing of every partial filling, and real-time updating of the record each time a partial filling occurs. An inspector who cannot reconcile what the automated dispensing system shows against what the pharmacy's own file shows treats the gap as a missing record, not a clerical error; our guide to the audit-ready controlled substance file and to inventory reconciliation cover the documentation DEA expects to see.
Why Early Legal Counsel Is Critical
It is critical that a long-term care facility pharmacy promptly retain experienced healthcare defense counsel upon receiving notice of a DEA inspection, a request for records, or a subpoena. Early legal intervention can protect the pharmacy's rights, help shape appropriate responses to government requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the pharmacy's behalf. Delaying legal representation can significantly affect the outcome of a matter, and an unresponsive or disorganized pharmacy risks a DEA order to show cause before the registration question is ever fully litigated.
How Health Law Alliance Can Help
Health Law Alliance represents pharmacies, physicians, distributors, and manufacturers in DEA defense matters, from registration applications and inspections through any order to show cause that follows.
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.
If a long-term care facility pharmacy has received notice of a DEA inspection or a request for automated dispensing system records, contact Health Law Alliance's DEA defense team for a free, confidential consultation.
